Back to Menu
Nasopharyngeal Carcinoma Treatment Modalities
1.Intensity-modulated radiotherapy (IMRT)
Radiation intensity is precisely controlled by computer planning to conform the high-dose region to the tumor shape.
2.Volumetric modulated arc therapy (VMAT)
A more advanced rotational IMRT technique that enables rapid and precise irradiation of complex target volumes.
3.Image-guided radiotherapy (IGRT)
Pre-treatment imaging verification is used to ensure accurate positioning and to enable timely plan adjustments.
4.Induction chemotherapy
Administered before radiotherapy to reduce tumor burden, commonly using regimens such as TPF or GP.
5.Concurrent chemoradiotherapy
Chemotherapy (e.g., cisplatin) is delivered concurrently with radiotherapy to improve local control and survival.
6.Adjuvant chemotherapy
Administered after radiotherapy to eradicate residual disease; implementation requires individualized assessment.
7.Targeted therapy
For example, nimotuzumab combined with radiotherapy may enhance radiosensitivity of tumor cells.
8.Immunotherapy
PD-1 inhibitors are used for recurrent or metastatic disease to activate the immune system against tumor cells.
9.Endoscopic endonasal surgery
Primarily used as a minimally invasive salvage approach for residual or recurrent lesions after radiotherapy.
Conclusion
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes the importance of early diagnosis and standardized treatment of nasopharyngeal carcinoma. Screening of high-risk populations, individualized multimodal strategies (e.g., radiotherapy and targeted therapy), and MDT-based multidisciplinary collaboration can substantially improve treatment outcomes and quality of survival.
Nasopharyngeal Carcinoma Treatment Modalities
1.Intensity-modulated radiotherapy (IMRT)
Radiation intensity is precisely controlled by computer planning to conform the high-dose region to the tumor shape.
2.Volumetric modulated arc therapy (VMAT)
A more advanced rotational IMRT technique that enables rapid and precise irradiation of complex target volumes.
3.Image-guided radiotherapy (IGRT)
Pre-treatment imaging verification is used to ensure accurate positioning and to enable timely plan adjustments.
4.Induction chemotherapy
Administered before radiotherapy to reduce tumor burden, commonly using regimens such as TPF or GP.
5.Concurrent chemoradiotherapy
Chemotherapy (e.g., cisplatin) is delivered concurrently with radiotherapy to improve local control and survival.
6.Adjuvant chemotherapy
Administered after radiotherapy to eradicate residual disease; implementation requires individualized assessment.
7.Targeted therapy
For example, nimotuzumab combined with radiotherapy may enhance radiosensitivity of tumor cells.
8.Immunotherapy
PD-1 inhibitors are used for recurrent or metastatic disease to activate the immune system against tumor cells.
9.Endoscopic endonasal surgery
Primarily used as a minimally invasive salvage approach for residual or recurrent lesions after radiotherapy.
Conclusion
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes the importance of early diagnosis and standardized treatment of nasopharyngeal carcinoma. Screening of high-risk populations, individualized multimodal strategies (e.g., radiotherapy and targeted therapy), and MDT-based multidisciplinary collaboration can substantially improve treatment outcomes and quality of survival.